缩写名/全名 |
MOL ONCOL
Molecular Oncology |
||||||||||||||||||||||||||||
ISSN号 | 1574-7891 | ||||||||||||||||||||||||||||
研究方向 | 医学-肿瘤学 | ||||||||||||||||||||||||||||
影响因子 | 2015:5.367, 2016:5.314, 2017:5.264, 2018:5.962, 2019:6.574, | ||||||||||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||||||||||
出版周期 | Quarterly | ||||||||||||||||||||||||||||
年文章数 | 173 | ||||||||||||||||||||||||||||
出版年份 | 2007 | ||||||||||||||||||||||||||||
是否OA | Yes | ||||||||||||||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||||||||||
录用比例 | |||||||||||||||||||||||||||||
投稿链接 | http://ees.elsevier.com/molonc/ | ||||||||||||||||||||||||||||
投稿官网 | http://www.moloncol.org/ | ||||||||||||||||||||||||||||
h-index | 71 | ||||||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1574-7891%5BISSN%5D | ||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways. Author: Tong X, Barbour M, Hou K, Gao C, Cao S, Zheng J, Zhao Y, Mu R, Jiang HR. Journal: Mol Oncol. 2016 Jan;10(1):113-25. doi: 10.1016/j.molonc.2015.06.004. Epub 2015 Sep 9. PubMed |
2. | 5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin. Author: Fatima S, Shi X, Lin Z, Chen GQ, Pan XH, Wu JC, Ho JW, Lee NP, Gao H, Zhang G, Lu A, Bian ZX. Journal: Mol Oncol. 2016 Feb;10(2):195-212. doi: 10.1016/j.molonc.2015.09.008. Epub 2015 Sep 30. PubMed |
3. | CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway. Author: Tang Z, Yu W, Zhang C, Zhao S, Yu Z, Xiao X, Tang R, Xuan Y, Yang W, Hao J, Xu T, Zhang Q, Huang W, Deng W, Guo W. Journal: Mol Oncol. 2016 Feb;10(2):317-29. doi: 10.1016/j.molonc.2015.10.015. Epub 2015 Nov 5. PubMed |
4. | hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers. Author: Xuan Y, Wang J, Ban L, Lu JJ, Yi C, Li Z, Yu W, Li M, Xu T, Yang W, Tang Z, Tang R, Xiao X, Meng S, Chen Y, Liu Q, Huang W, Guo W, Cui X, Deng W. Journal: Mol Oncol. 2016 Apr;10(4):610-24. doi: 10.1016/j.molonc.2015.11.010. Epub 2015 Nov 30. PubMed |
5. | Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals. Author: Chen ZJ, Wei W, Jiang GM, Liu H, Wei WD, Yang X, Wu YM, Liu H, Wong CK, Du J, Wang HS. Journal: Mol Oncol. 2016 Jun;10(6):775-88. doi: 10.1016/j.molonc.2016.01.002. Epub 2016 Jan 18. PubMed |
6. | Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs. Author: Cheng X, Kim JY, Ghafoory S, Duvaci T, Rafiee R, Theobald J, Alborzinia H, Holenya P, Fredebohm J, Merz KH, Mehrabi A, Hafezi M, Saffari A, Eisenbrand G, Hoheisel JD, Wölfl S. Journal: Mol Oncol. 2016 Jun;10(6):806-24. doi: 10.1016/j.molonc.2016.01.008. Epub 2016 Feb 4. PubMed |
7. | MicroRNA-548j functions as a metastasis promoter in human breast cancer by targeting Tensin1. Author: Zhan Y, Liang X, Li L, Wang B, Ding F, Li Y, Wang X, Zhan Q, Liu Z. Journal: Mol Oncol. 2016 Jun;10(6):838-49. doi: 10.1016/j.molonc.2016.02.002. Epub 2016 Feb 23. PubMed |
8. | Novel sesquiterpene lactone analogues as potent anti-breast cancer agents. Author: Nakagawa-Goto K, Chen JY, Cheng YT, Lee WL, Takeya M, Saito Y, Lee KH, Shyur LF. Journal: Mol Oncol. 2016 Jun;10(6):921-37. doi: 10.1016/j.molonc.2016.03.002. Epub 2016 Mar 25. PubMed |
9. | Improving fascin inhibitors to block tumor cell migration and metastasis. Author: Han S, Huang J, Liu B, Xing B, Bordeleau F, Reinhart-King CA, Li W, Zhang JJ, Huang XY. Journal: Mol Oncol. 2016 Apr 1. pii: S1574-7891(16)30013-8. doi: 10.1016/j.molonc.2016.03.006. [Epub ahead of print] PubMed |
10. | SW43-DOX ± loading onto drug-eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment - An in vitro evaluation. Author: Ludwig JM, Gai Y, Sun L, Xiang G, Zeng D, Kim HS. Journal: Mol Oncol. 2016 May 21. pii: S1574-7891(16)30038-2. doi: 10.1016/j.molonc.2016.05.003. [Epub ahead of print] PubMed |
|
|